BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6697367)

  • 1. [Comparison of biochemical and immunological indicators in chronic liver diseases].
    Bendová J; Chenícková M
    Cas Lek Cesk; 1984 Feb; 123(7):186-91. PubMed ID: 6697367
    [No Abstract]   [Full Text] [Related]  

  • 2. [The significance of immunological indicators in the diagnosis of chronic diseases of the liver].
    Iakhontova OI; Karashurova LL; Starkova SA
    Vrach Delo; 1988 Apr; (4):39-41. PubMed ID: 3261058
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinico-prognostic significance of partial seroconversion in chronic viral hepatitis B follow-up. Wartenbert Study (1974-1994), II].
    Ohlen I; Liegl JM; Selmair H
    Leber Magen Darm; 1995 Dec; 25(6):259-62. PubMed ID: 8577215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinical significance of immunoglobulin E in chronic liver diseases].
    Iakhontova OI; Dudanova OP
    Ter Arkh; 1990; 62(2):87-90. PubMed ID: 2336631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytotoxic activity of the lymphocytes in patients with chronic hepatitis and liver cirrhosis].
    Mokhov VM; Lisok TP; Petrov AL
    Ter Arkh; 1983; 55(2):43-5. PubMed ID: 6601859
    [No Abstract]   [Full Text] [Related]  

  • 6. [Variations in the metabolism of iron in chronic liver diseases].
    Povés E; Moreno Otero R; Estrada A; Del Pozo A; Ruiz Ayuso F; Cantero J; Pajares JM
    Rev Esp Enferm Apar Dig; 1988 Jan; 73(1):17-21. PubMed ID: 3363200
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunologic abnormalities, quantitative and qualitative, in chronic active liver disease].
    Banciu T; Arcan P; Darlea L; Căpălnăşan I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1987; 39(3):267-72. PubMed ID: 2891175
    [No Abstract]   [Full Text] [Related]  

  • 8. The expression of bcl-2 in chronic liver diseases.
    Mutluay R; Ozenirler S; Poyraz A
    Saudi Med J; 2005 Aug; 26(8):1245-9. PubMed ID: 16127523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of tissue polypeptide specific antigen as a marker in liver diseases.
    Cetin T; Oğuz A; Algan P; Yildirim IS
    Turk J Gastroenterol; 2003 Sep; 14(3):177-80. PubMed ID: 14655061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surgical risk to chronic liver patients].
    Fluture V; Onisei O; Preda A; Grosu M
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1983; 32(3):185-98. PubMed ID: 6240673
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic hepatitis evolution in cancer patients.
    Ortíz-Lazcano S; Sotelo-Núñez MD; Labastida-Almendaro S; Castro-Hernández L
    Arch Invest Med (Mex); 1983; 14(1):65-71 passim. PubMed ID: 6838312
    [No Abstract]   [Full Text] [Related]  

  • 12. [The functional-morphological state of the liver in chronic opisthorchiasis].
    Tun MA; Beloborodova EI; Iushkova GI; Soldatova LP
    Ter Arkh; 1991; 63(11):63-6. PubMed ID: 1810068
    [No Abstract]   [Full Text] [Related]  

  • 13. Autoantibodies in chronic liver diseases.
    Panasiuk A
    Rocz Akad Med Bialymst; 2001; 46():106-12. PubMed ID: 11780553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variant liver estrogen receptor transcripts already occur at an early stage of chronic liver disease.
    Villa E; Dugani A; Moles A; Camellini L; Grottola A; Buttafoco P; Merighi A; Ferretti I; Esposito P; Miglioli L; Bagni A; Troisi R; De Hemptinne B; Praet M; Callea F; Manenti F
    Hepatology; 1998 Apr; 27(4):983-8. PubMed ID: 9537437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decision-making model for a non-invasive diagnosis of compensated liver cirrhosis.
    Marmo R; Romano M; de Sio I; Peduto A; Caporaso N; Persico M; Coltorti M
    Ital J Gastroenterol; 1993 Jan; 25(1):1-8. PubMed ID: 8428017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibodies against hepatitis B virus in chronic non-alcoholic HBsAg-negative hepatopathies].
    Moreira Vicente VF; Simón Marco MA; Pascasio Acevedo JM; Ruiz del Arbol Olmos L; Larraona Moreno JL; González Martín JA; Aguilera Musso D; Barcena Marugan R; Bueno Vallejo R
    Med Clin (Barc); 1984 Mar; 82(12):522-30. PubMed ID: 6738151
    [No Abstract]   [Full Text] [Related]  

  • 17. [Expression of matrix metalloproteinase-2 and its tissue inhibitor in liver tissue of patients with chronic hepatitis and cirrhosis].
    Wang YC; Wang YD
    Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):248-9. PubMed ID: 15099487
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunological indicators in chronic hepatitis and liver cirrhosis].
    Podymova SD; Bon KU
    Sov Med; 1980; (12):38-41. PubMed ID: 6971495
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-tissue transglutaminase antibodies in patients with abnormal liver tests: is it always coeliac disease?
    Lo Iacono O; Petta S; Venezia G; Di Marco V; Tarantino G; Barbaria F; Mineo C; De Lisi S; Almasio PL; Craxì A
    Am J Gastroenterol; 2005 Nov; 100(11):2472-7. PubMed ID: 16279902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum IgA level--one more indicator of the morphological and functional state of liver cells].
    Jarkowska-Kozłowska J; Jasińska A; Jabłkowski M
    Przegl Lek; 1986; 43(4):357-61. PubMed ID: 3749519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.